Finals Reporting Flashcards

1
Q

systematic assessment of a patient’s medication management

aim:
optimize quality use of medicines minimize medication-related problems.

A

MEDICATION REVIEW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

a multidisciplinary responsibility that ensures the ongoing safe and
effective use of medicines at
all stages of the medication
management pathway.

A

MEDICATION REVIEW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TYPES OF MEDICATION REVIEW

A

MEDICATION ORDER REVIEW
MEDICATION ADHERENCE REVIEW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

review of individual medication orders and/or prescription validity. It may take place w/o the patient present.

A

MEDICATION ORDER REVIEW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

review of a patient’s medicine-taking behavior (how they actually take their medicines and what their beliefs about medicines are).

A

MEDICATION ADHERENCE REVIEW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

comprehensive review of a patient’s medicines in the context of their clinical conditions. Partnering with the patient/carer is essential.

A

clinical medication review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Conducting ______ medication reviews can optimize the medications used and reduce medicine-related problems.

A

evidence-based

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In conducting amedication review it should be based on the ______.
-knowledge of processes for managing medicines,
-therapeutic knowledge on medicines use,
- ability to effectively communicate

A

clinicians’ knowledge and skill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The delivery models for medication review are just the same across health service organizations.

T or F

A

F

may vary across

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patients with a higher risk of experiencing medication-related harm should be given priority.
Risk assessment and stratification should be based on evidence and local organizational priorities.

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A reduction in efficacy due to an
interaction can sometimes be just as
harmful as an increase.

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A reduction in efficacy due to an
interaction can sometimes be just as
harmful as an increase.

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

it is said to occur when the effects of one drug are changed by the presence of another drug, herbal medicine, food, drink or by some environmental chemical agent.

A

interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The more drugs a patient takes the
lesser the likelihood that an adverse
reaction will occur.

T or F

A

F

greater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug interaction incidence is
expected to be higher in the adults
because ageing affects the functioning of the kidneys and liver.

T or F

A

F

Elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treating patients with more than one drug at a time is extremely risky. Some quite essential drug interactions remained virtually unnoticed for many years.

T or F

A

T

17
Q

5 Patient factors contributing to DI:

A

Age
Drug dose
Serum drug level
Drug metabolism
Polypharmacy

18
Q

_____interactions are those that can affect the processes by which drugs are absorbed, distributed, metabolized and excreted (the so- called ADME interactions).

A

Pharmacokinetic

19
Q

Drug Absorption Interactions:

A
  • Effects of changes in gastrointestinalI pH
  • Adsorption, chelation & other complexing mechanisms
  • Changes in gastrointestinal motility
  • Induction or inhibition of drug transporter proteins
    Malabsorption caused by drugs
20
Q

Drug Distribution Interactions:

A
  • Protein-binding interactions
  • Induction or inhibition of drug transport proteins
21
Q

Drug Metabolism (Biotransformation) Interactions:

A

Changes in first-pass metabolism
Enzyme induction
Enzyme inhibition
Genetic factors in drug metabolism
Cytochrome P450 isoenzymes & predicting drug interactions

22
Q

(involving oxidation, reduction
or hydrolysis), turn drugs into more polar compounds

A

phase I reactions (functionalization)

23
Q

coupling drugs with some other substance (e.g. glucuronic acid, known as glucuro- nidation) to make usually inactive compounds.

A

phase II reactions (conjugation)

24
Q

Drug Excretion Interactions:

A

Changes in urinary pH
Changes in active renal tubular excretion
Changes in renal blood flow
Biliary excretion & the entero-hepatic shunt

25
Q

are those where the effects of one drug are changed by the presence of
another drug at its site of action.

A

Pharmacodynamic interactions

26
Q

If two drugs that have the same pharmacological effect are given together the effects can be additive.

A

Additive or Synergistic Interactions

27
Q

pairs of drugs with activities that are opposed to one another.

A

Antagonistic or Opposing Interactions

28
Q

number of drugs with actions that occur at adrenergic neurons can be prevented from reaching those sites
of action by the presence of other drugs.

A

Drug or Neurotransmitters Uptake Interactions

29
Q

they prevent the reuptake of noradrenaline (norepinephrine) into peripheral adrenergic neurons.

A

tricyclic antidepressants

30
Q

what type of drugs are most susceptible to alterations of GI absorption?

A

drugs that are not absorbed completely under optimum circumstances

31
Q

by increasing Gl motility, may increase the rate at which another drug passes through the GI tract.

A

CATHARTICS

32
Q

by decreasing GI motility, also
may influence drug absorption

A

ANTICHOLINERGICS

33
Q

increases motility of the
upper GI tract,

A

METOCLOPRAMIDE